- Home
- Features
- News
- Topics
- Labor
- Management
- Opinions/Blogs
- Tools & Resources
ZURICH (Reuters) – The 70-year-old son of a Swiss butcher is among the biggest beneficiaries of Johnson & Johnson’s $30 billion takeover of Actelion, Europe’s biggest biotech company.
Source:: Medical couple and butcher's boy win big from Actelion sale